Brookstone Capital Management Regeneron Pharmaceuticals, Inc. Transaction History

Brookstone Capital Management

  • $6.01 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 03, 2021
SELL
$574.03 - $680.96 $246,258 - $292,131
-429 Closed
0 $0
Q2 2021

Jul 14, 2021
BUY
$472.8 - $558.54 $202,831 - $239,613
429 New
429 $248,000
Q3 2020

Oct 13, 2020
SELL
$544.75 - $658.21 $1.03 Million - $1.25 Million
-1,897 Closed
0 $0
Q2 2020

Jul 21, 2020
BUY
$493.32 - $643.92 $935,828 - $1.22 Million
1,897 New
1,897 $1.18 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email